Drug Trial Radar · NCT00007605
Comparing the Effects of Amiodarone, Sotalol, and Placebo in Maintaining Sinus Rhythm in Patients With Atrial Fibrillation Converted to Sinus Rhythm
Last checked: Nov 19, 2026Latest source record: Jun 15, 2011 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
706
Planned (sponsor's estimate)
Start
Apr 1998
Primary completion
Oct 2002
Study completion Dec 2003
Sponsor
- Lead sponsor
- US Department of Veterans AffairsFederal agency
- Sponsor type
- Federal agency
- First posted
- Jan 1, 2001
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Crossover
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- Who can join
- All sexes
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Atrial fibrillation is the most frequently occurring cardiac arrhythmia, with 1.0-1.5 million cases annually. It is a risk factor for congestive heart failure, and stroke, 75,000 cases of the latter occurring annually in patients with atrial fibrillation. The safety of the most widely used antiarrhythmic agent for this group of patients, quinidine, has been called into question. This study seeks to determine whether two other agents, amiodarone and sotalol, are safe and effective treatments for patients with atrial fibrillation.
Conditions
- Atrial Fibrillation
- Cerebrovascular Accident
- Death, Sudden
Interventions
AmiodaroneDrug
Patients assigned will receive 400 mg bid for 14 days, 400 mg QAM and 200 mg QHS for 14 days, 300 mg qd for 48 weeks, then 200 mg qd.
SotalolDrug
Patients assigned will receive 80 mg bid for 7 days and 160 mg bid thereafter.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Treatment failure, defined as occurrence of atrial fibrillation or flutter after day 28 or failure to convert to sinus rhythm.Time frame: After day 28
Locations
28 sites in 1 country. Site status is shown where the registry gives one.
Southern Arizona VA Health Care System, Tucson
Tucson, Arizona
Central Arkansas VHS Eugene J. Towbin Healthcare Ctr, Little Rock
No. Little Rock, Arkansas
VA Central California Health Care System, Fresno
Fresno, California
VA Medical Center, Loma Linda
Loma Linda, California
VA Palo Alto Health Care System
Palo Alto, California
VA Greater Los Angeles HCS, Sepulveda
Sepulveda, California
VA Greater Los Angeles Healthcare System, West LA
West Los Angeles, California
VA Connecticut Health Care System (West Haven)
West Haven, Connecticut
VA Medical Center, DC
Washington D.C., District of Columbia
VA Medical Center, Bay Pines
Bay Pines, Florida
James A. Haley Veterans Hospital, Tampa
Tampa, Florida
VA Medical Center, Augusta
Augusta, Georgia
Edward Hines, Jr. VA Hospital
Hines, Illinois
VA Medical Center, Iowa City
Iowa City, Iowa
VA Boston Healthcare System, Brockton Campus
Brockton, Massachusetts
VA Medical Center, Minneapolis
Minneapolis, Minnesota
VA Medical Center, Kansas City MO
Kansas City, Missouri
VA Medical Center, St Louis
St Louis, Missouri
New Mexico VA Health Care System, Albuquerque
Albuquerque, New Mexico
VA Medical Center, Fargo
Fargo, North Dakota
VA Medical Center, Portland
Portland, Oregon
VA Pittsburgh Health Care System
Pittsburgh, Pennsylvania
VA Medical Center, Providence
Providence, Rhode Island
VA Medical Center, Memphis
Memphis, Tennessee
VA Medical Center
Nashville, Tennessee
VA North Texas Health Care System, Dallas
Dallas, Texas
Hunter Holmes McGuire VA Medical Center
Richmond, Virginia
Wlliam S. Middleton Memorial Veterans Hospital, Madison
Madison, Wisconsin
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.